Aravive, Inc. ARAV
0.04 +0.04
Quote time unavailable
Day range unavailable
52-week range unavailable
News
globenewswire.com Kratos ARAV-B Ballistic Missile Target Successfully Utilized In Multinational Pacific Dragon 2026 Exercise Photo: U.S. Navy https://www.navy.mil/Press-Office/News-Stories/display-news/Article/4575192/us-allies-partners-executed-pacific-dragon-2026-exercise/ A photo accompanying this announcement is…
globenewswire.com Kratos' Aegis Readiness Assessment Vehicle Type B (ARAV-B) Medium-Range Ballistic Missile Target Successfully Engaged, Intercepted by U.S. Guided Missile Destroyers USS Bulkeley (DDG-84) and USS Thomas Hudner (DDG-116) Using Standard Missile 3 (SM-3) SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a technology company in Defense, National Security and Global Markets, today announced its…
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
investorplace.com Why Is Aravive (ARAV) Stock Down 52% Today? Aravive (NASDAQ: ARAV ) stock is taking a beating on Thursday as the clinical-stage biopharmaceutical company prepares for its shares to be delisted from the Nasdaq Exchange. A press release from…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session 
proactiveinvestors.com Aravive stock slumps on Nasdaq delisting plan, dissolution Aravive Inc's shares fell over 58% in Thursday premarket trading after it announced plans to voluntarily delist its common stock on Nasdaq as it prepares to dissolve the company. In a statement, the…
globenewswire.com Aravive, Inc. to Delist from The Nasdaq Stock Market HOUSTON, Jan. 17, 2024 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), announced today that the Company intends to voluntarily terminate the listing of its common stock on the Nasdaq…
pennystocks.com Penny Stocks To Buy? Watch These 3 Under $5 Before Next Week Penny stocks have not been as popular as you might think over the last few weeks. Thanks to plenty of economic uncertainty and concerns over inflation, investors have pulled back on risk.
benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session 
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session 
zacks.com Aravive (ARAV) Upgraded to Strong Buy: What Does It Mean for the Stock? Aravive (ARAV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 210 companies reached new 52-week lows.- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023
zacks.com Aravive (ARAV) Reports Q2 Loss, Tops Revenue Estimates Aravive (ARAV) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.61 per share a year ago.
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday's session, 92 stocks hit new 52-week lows.
- benzinga.com Why Cummins Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Gainers Bluejay Diagnostics, Inc. (NASDAQ: BJDX) shares jumped 75% to $9.60.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2023 
investorplace.com Why Is Aravive (ARAV) Stock Down 58% Today? Aravive (NASDAQ: ARAV ) stock is plummeting on Thursday following the release of results from a Phase 3 clinical trial. The bad news hitting ARAV stock today is that its Phase 3 AXLerate-OC trial did…
globenewswire.com Aravive Announces Top-Line Results from Phase 3 AXLerate-OC Study of Batiraxcept in Platinum-Resistant Ovarian Cancer HOUSTON, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today…
globenewswire.com Aravive to Present Updated Clinical Data from Batiraxcept Trials in Renal and Pancreatic Cancer at ESMO Congress 2023 HOUSTON, July 28, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today…
globenewswire.com Aravive to Participate in William Blair's Innovator Series: Transitioning Biotech Breakthroughs to Commercial Success Being Held July 18, 2023 HOUSTON, July 14, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease today…
investorplace.com 3 Short-Squeeze Stocks Set for a Spectacular Gamma Squeeze Rally At the heart of every idea for short-squeeze stocks to buy is the ability to make a massive amount of money in a short time period. For a quick recap, those attempting to spark a gamma squeeze…
globenewswire.com Aravive To Participate in the Jefferies Global Healthcare Conference HOUSTON, June 05, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease today…
globenewswire.com Aravive to Present Promising Updated Data from Phase 2 Trial of Batiraxcept in Combination with Cabozantinib in Clear Cell Renal Cell Carcinoma at ASCO 2023 HOUSTON, May 25, 2023 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV, “the Company”), a late clinical-stage oncology company developing targeted therapeutics to treat metastatic disease, today…
investorplace.com 7 Short-Interest Stocks to Target for Explosive Gains Ranking among the most speculative practices in the equities arena, deliberately bidding up short-interest stocks may generate wildly robust gains. At the same time, higher risks for the intrepid…
zacks.com What Makes Aravive (ARAV) a New Buy Stock Aravive (ARAV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
investorplace.com 7 Short-Squeeze Stocks That Are Driving Hedge Funds Crazy Although the concept of gambling on short-squeeze stocks present risks, certain market ideas drive hedge funds crazy. By this statement, I'm referring to companies that speculators believe in their…
investorplace.com 7 Short-Squeeze Stocks That Could Explode in April While an extremely risky proposition, short-squeeze stocks – as meme traders demonstrated – can occasionally yield radical profitability. However, you don't want to just pick any beaten-down security…
zacks.com Aravive (ARAV) Reports Q4 Loss, Tops Revenue Estimates Aravive (ARAV) delivered earnings and revenue surprises of -39.39% and 298.38%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 - benzinga.com Why Harsco Shares Surged Over 22%; Here Are 80 Biggest Movers From Yesterday Gainers
- benzinga.com Why Abiomed Shares Are Trading Higher By Over 50%? Here Are 60 Stocks Moving In Tuesday's Mid-Day Session Gainers Safe-T Group Ltd (NASDAQ: SFET) shares surged 63.7% to $0.4910 as the company said its privacy application reached over 5,000,000 downloads.
- benzinga.com Why Virios Therapeutics Is Trading Lower By 75%, Here Are 44 Stocks Moving In Tuesday's Mid-Day Session Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 51% to $0.4957. Crown ElectroKinetics, last month, posted a Q4 net loss of $4.5 million.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 120 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 195 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 109 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 120 companies achieved new lows for the year.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 100 companies reached new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Friday On Friday, 137 stocks made new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's session, 539 stocks hit new 52-week lows.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For June 3, 2022
- benzinga.com Stocks That Hit 52-Week Lows On Thursday During Thursday, 849 stocks hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday On Tuesday, 242 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 466 companies hit new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 90 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Tuesday Tuesday morning, 282 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday morning, 207 companies hit new 52-week lows.
- benzinga.com 100 Biggest Movers From Thursday Gainers Independence Contract Drilling, Inc. (NYSE: ICD) shares jumped 160.4% to close at $6.25 on Thursday.